Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How the Indestructible Molecule that is PFAS Effects the Environment

In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked about just what PFAS is, and why the molecules’ existence is harmful.

PFAS is a manmade chemical that repels water and oil, which also makes it a highly preferable component for some commonly-used products. This can include cookware, food wrappings, and paint, according to Li. The first use of PFAS began in the 1940s, and it evidently found its way into various products due to its resistant qualities. And due to that fact, the initial inference of the safety of PFAS was misleading, per Li.

“There is no natural occurrence of this type of molecule, and because everything gets repelled from it, there was always this assumption early on when it was invented, that it’s harmless,” said Li.

But decades later and after many studies, even by the U.S. Environmental Protection Agency (EPA), it has been concluded the concerns regarding PFAS are major harm to the environment and living beings.

PFAS does not break down into the environment the way other molecules can, which means it presents a different type of danger for the environment. And just based on bioaccumulation, PFAS’ has found its way into every living organism, said Li.

Current studies are still in the early stages of determining just how toxic PFAS can be to the human body, and what levels would be considered a cause for immediate concern. But there is a connection between it and other health issues, said Li.

“Some of the early links were cancers, thyroid issues is one of the biggest ones being investigated at the moment, and pregnancy issues,” said Li.

People with major thyroid problems and hormonal imbalances were shown to have a lot of exposure to PFAS, added Li. But he stated that the studies between PFAS and infertility is a growing concern that is taking precedence.

Even more daunting is the formidablilty of PFAS. Being that it cannot break down environmentally, that also means it doesn’t break down in the body either. Subsequently, the response for health issues or symptoms related to PFAS is basic treatment. But even treatment like chemotherapy or cancer medications can’t break down the substance.

Li joked that even diamonds aren’t as long-lasting, and stated that PFAS is expected to be around for a long time due to the weight of effort that even needs to be made just to fully eliminate it. For example, if PFAS ends up in wildlife, it is expected to be there practically forever.

“It will take millions of years before they would even begin to start breaking down — that’s how strong that molecules’ bonds are,” said Li. “Right now the only method really of getting rid of PFAS is really high heat incineration.”

Only extremely high heat can destroy PFAS, but even if that method was widely utilized, it would create another domino effect of environmental issues such as harming the natural water supply.

The Industry That is Depending on Science and Regulation to Grow

Is Cryptocurrency and Its Tech Infrastructure Ready for a Revolution?

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512